Alcohol metabolism in alcohol use disorder: a potential therapeutic target
Alcohol and Alcoholism · 11.01.2024 · 59 (1)
DOI: 10.1093/alcalc/agad077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alcohol and Alcoholism, online erschienen am 09.11.2023. Verfasst von Taylor Lehner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Bethesda, MD 2089…. Hauptthemen laut MEDLINE: Alcoholism. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH, NIAAA.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Ethanol metabolism plays an essential role in how the body perceives and experiences alcohol consumption, and evidence suggests that modulation of ethanol metabolism can alter the risk for alcohol use disorder (AUD). In this review, we explore how ethanol metabolism, mainly via alcohol dehydrogenase and aldehyde dehydrogenase 2 (ALDH2), contributes to drinking behaviors by integrating preclinical and clinical findings. We discuss how alcohol dehydrogenase and ALDH2 polymorphisms change the risk for AUD, and whether we can harness that knowledge to design interventions for AUD that alter ethanol metabolism. We detail the use of disulfiram, RNAi strategies, and kudzu/isoflavones to inhibit ALDH2 and increase acetaldehyde, ideally leading to decreases in drinking behavior. In addition, we cover recent preclinical evidence suggesting that strategies other than increasing acetaldehyde-mediated aversion can decrease ethanol consumption, providing other potential metabolism-centric therapeutic targets. However, modulating ethanol metabolism has inherent risks, and we point out some of the key areas in which more data are needed to mitigate these potential adverse effects. Finally, we present our opinions on the future of treating AUD by the modulation of ethanol metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Bethesda, MD 20892, United States.
ORCID-Profile: Bryan Mackowiak
Förderung
- NIH
- NIAAA
Zitieren
APA
Lehner, T., Gao, B., & Mackowiak, B. (2024). Alcohol metabolism in alcohol use disorder: a potential therapeutic target. Alcohol and Alcoholism, 59(1). https://doi.org/10.1093/alcalc/agad077
Vancouver
Lehner T, Gao B, Mackowiak B. Alcohol metabolism in alcohol use disorder: a potential therapeutic target. Alcohol and Alcoholism. 2024;59(1). doi:10.1093/alcalc/agad077
BibTeX
@article{Lehner2024,
author = {Lehner, Taylor and Gao, Bin and Mackowiak, Bryan},
title = {Alcohol metabolism in alcohol use disorder: a potential therapeutic target},
journal = {Alcohol and Alcoholism},
year = {2024},
volume = {59},
number = {1},
doi = {10.1093/alcalc/agad077}
}
EUVIMED